MedTrace Logo

Native Coronary Artery Instead of SAphenous Vein Graft Intervention for Treatment of Significant Saphenous Vein Graft Lesions

NCT05187351 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 99

Last updated 2025-01-27

No results posted yet for this study

Summary

The primary study objective of the NASA registry is to evaluate the 12-month incidence of target vessel failure (TVF) in patients who present with saphenous vein graft (SVG) lesions and undergo percutaneous coronary intervention (PCI) of the corresponding native coronary artery.

Conditions

  • Target Vessel Failure in Saphenous Vein Grafts
  • Percutaneous Coronary Intervention

Interventions

PROCEDURE

Percutaneous coronary intervention of the native coronary artery with Synergy

This is a registry study that will enroll patients with a 50-100% de novo SVG lesion and treated with percutaneous coronary intervention of the corresponding native coronary artery using a SYNERGY stent.

Sponsors & Collaborators

  • Minneapolis Heart Institute Foundation

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-21
Primary Completion
2030-01-31
Completion
2030-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05187351 on ClinicalTrials.gov